Bortezomib and/or Daratumumab for Treatment of Refractory Autoimmune Hemolytic Anemia

被引：0
|
作者：
McGlothlin, John [1 ]
Abeykoon, Jithma P. [2 ]
Al-Hattab, Eyad [2 ]
Ashrani, Aneel A. [2 ]
Elliott, Michelle A. [2 ]
Go, Ronald [2 ]
Hook, C. Christopher [2 ]
Pardanani, Animesh [2 ]
Pruthi, Rajiv K. [2 ]
Sridharan, Meera [2 ]
Wolanskyj, Alexandra P. [2 ]
机构：
[1] Mayo Clin, Dept Internal Med, Rochester, MN USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-159270
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5328 / 5330
页数：3
相关论文
共 50 条
  • [41] Rituximab in Severe Refractory Autoimmune Hemolytic Anemia in Children
    Nagaraj, Ravishankar
    Alsherida, Sundus
    Adekile, Adekunle
    KUWAIT MEDICAL JOURNAL, 2009, 41 (03): : 257 - 260
  • [42] Rapid response to a single-dose rituximab combined with bortezomib in refractory and relapsed warm autoimmune hemolytic anemia
    Chen, Miao
    Zhuang, Junling
    Yang, Chen
    Zhang, Lu
    Wang, Wei
    Cai, Huacong
    Yu, Yanfang
    Li, Jian
    Zhou, Daobin
    Han, Bing
    ANNALS OF HEMATOLOGY, 2020, 99 (05) : 1141 - 1143
  • [43] Rituximab for Treatment of Autoimmune Hemolytic Anemia
    Kuzmanovic, Milos
    Jurisic, Vladimir
    INDIAN PEDIATRICS, 2012, 49 (08) : 672 - 674
  • [44] Rapid response to a single-dose rituximab combined with bortezomib in refractory and relapsed warm autoimmune hemolytic anemia
    Miao Chen
    Junling Zhuang
    Chen Yang
    Lu Zhang
    Wei Wang
    Huacong Cai
    Yanfang Yu
    Jian Li
    Daobin Zhou
    Bing Han
    Annals of Hematology, 2020, 99 : 1141 - 1143
  • [45] Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease (vol 8, pg 2622, 2024)
    Jalink, Marit
    Jacobs, Chaja F.
    Khwaja, Jahanzaib
    Evers, Dorothea
    Bruggeman, Coty
    Fattizzo, Bruno
    Michel, Marc
    Crickx, Etienne
    Hill, Quentin A.
    Jaeger, Ulrich
    Kater, Arnon P.
    Makelburg, Anja B. U.
    Breedijk, Anouk
    Boekhorst, Peter A. W. Te
    Hoeks, Marlijn P. A.
    de Haas, Masja
    D'Sa, Shirley
    Vos, Josephine M., I
    BLOOD ADVANCES, 2024, 8 (24) : 6267 - 6267
  • [46] TREATMENT OF AUTOIMMUNE HEMOLYTIC ANEMIA WITH HEPARIN
    TENPAS, A
    MONTO, RW
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1966, 251 (01): : 63 - &
  • [47] Bortezomib and rituximab in multiply relapsed primary warm autoimmune hemolytic anemia
    Ames, Paul R. J.
    Jeffrey, Susan
    ANNALS OF HEMATOLOGY, 2021, 100 (09) : 2415 - 2416
  • [48] Bortezomib and rituximab in multiply relapsed primary warm autoimmune hemolytic anemia
    Paul R. J. Ames
    Susan Jeffrey
    Annals of Hematology, 2021, 100 : 2415 - 2416
  • [49] BORTEZOMIB THERAPY IN A REFRACTORY IMMUN HEMOLYTIC ANEMIA AS A STEROID SPARING AGENT
    Dincyurek, Huseyin Derya
    Mutlu, Yasa Gul
    Kis, Cem
    Guvenc, Birol
    LEUKEMIA RESEARCH, 2017, 61 : S49 - S49
  • [50] The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia
    Pamuk, Gulsum Emel
    Turgut, Burhan
    Demir, Muzaffer
    Tezcan, Fatma
    Vural, Ozden
    AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (08) : 631 - 633
12345